W Cools

1.9k total citations
27 papers, 1.6k citations indexed

About

W Cools is a scholar working on Molecular Biology, Pharmacology and Genetics. According to data from OpenAlex, W Cools has authored 27 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Pharmacology and 6 papers in Genetics. Recurrent topics in W Cools's work include Retinoids in leukemia and cellular processes (8 papers), Antifungal resistance and susceptibility (5 papers) and Estrogen and related hormone effects (5 papers). W Cools is often cited by papers focused on Retinoids in leukemia and cellular processes (8 papers), Antifungal resistance and susceptibility (5 papers) and Estrogen and related hormone effects (5 papers). W Cools collaborates with scholars based in Belgium and United States. W Cools's co-authors include G. Willemsens, W. Lauwers, H. Van den Bossche, M C Coene, Patrick Marichal, L. Le Jeune, Frans W. Cornelissen, J. Goossens, H. Vanden Bossche and J.M. Van Cutsem and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and British Journal of Cancer.

In The Last Decade

W Cools

27 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W Cools Belgium 16 767 318 286 243 221 27 1.6k
G. Willemsens Belgium 22 654 0.9× 451 1.4× 235 0.8× 355 1.5× 291 1.3× 29 1.8k
Gwenaëlle Conseil Canada 29 1.1k 1.4× 327 1.0× 136 0.5× 149 0.6× 226 1.0× 54 2.6k
M. Pinto France 12 1.2k 1.5× 219 0.7× 379 1.3× 91 0.4× 117 0.5× 23 2.5k
Jin‐Ching Lee Taiwan 35 1.2k 1.6× 533 1.7× 151 0.5× 463 1.9× 177 0.8× 99 3.0k
Pei‐Lan He China 26 697 0.9× 189 0.6× 185 0.6× 312 1.3× 174 0.8× 40 2.1k
Tohru Komano Japan 25 1.3k 1.7× 295 0.9× 289 1.0× 92 0.4× 184 0.8× 135 3.2k
Péter Krajcsi Hungary 32 1.3k 1.7× 373 1.2× 695 2.4× 246 1.0× 276 1.2× 92 3.2k
Hsue‐Yin Hsu Taiwan 21 607 0.8× 111 0.3× 151 0.5× 121 0.5× 92 0.4× 39 1.3k
Yi Ding China 28 1.9k 2.4× 746 2.3× 160 0.6× 146 0.6× 274 1.2× 99 3.4k
Pei‐Wen Hsiao Taiwan 31 1.8k 2.4× 352 1.1× 410 1.4× 275 1.1× 129 0.6× 78 3.4k

Countries citing papers authored by W Cools

Since Specialization
Citations

This map shows the geographic impact of W Cools's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Cools with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Cools more than expected).

Fields of papers citing papers by W Cools

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W Cools. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Cools. The network helps show where W Cools may publish in the future.

Co-authorship network of co-authors of W Cools

This figure shows the co-authorship network connecting the top 25 collaborators of W Cools. A scholar is included among the top collaborators of W Cools based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W Cools. W Cools is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cuyckens, Filip, et al.. (2012). Identifying Metabolite Ions of Peptide Drugs in The Presence of An In Vivo Matrix Background. Bioanalysis. 4(5). 595–604. 15 indexed citations
2.
Dillen, Lieve, et al.. (2010). A Screening UHPLC–MS/MS Method for The Analysis of Amyloid Peptides in Cerebrospinal Fluid of Preclinical Species. Bioanalysis. 3(1). 45–55. 17 indexed citations
3.
Freyne, Eddy, Frederik Deroose, Marc Willems, et al.. (2004). Synthesis and Biological Evaluation of 1,2,4-Triazinylphenylalkylthiazolecarboxylic Acid Esters as Cytokine-Inhibiting Antedrugs with Strong Bronchodilating Effects in an Animal Model of Asthma. Journal of Medicinal Chemistry. 48(6). 2167–2175. 9 indexed citations
4.
Verhoeven, A. J., Jacky Van Dun, W Cools, et al.. (1997). Induction of the oxidative catabolism of retinoic acid in MCF-7 cells. British Journal of Cancer. 75(8). 1098–1104. 15 indexed citations
5.
Ginckel, R. Van, et al.. (1996). Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors. The Prostate. 29(1). 36–41. 8 indexed citations
6.
Ginckel, R. Van, et al.. (1996). Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors. The Prostate. 29(1). 36–41. 4 indexed citations
7.
Wauwe, J. Van, M C Coene, W Cools, et al.. (1994). Liarozole fumarate inhibits the metabolism of 4-keto-all-trans-retinoic acid. Biochemical Pharmacology. 47(4). 737–741. 32 indexed citations
8.
Bossche, H. Vanden, Patrick Marichal, L. Le Jeune, et al.. (1993). Effects of itraconazole on cytochrome P-450-dependent sterol 14 alpha-demethylation and reduction of 3-ketosteroids in Cryptococcus neoformans. Antimicrobial Agents and Chemotherapy. 37(10). 2101–2105. 84 indexed citations
9.
Wauwe, J. Van, M C Coene, P. Stoppie, et al.. (1992). Liarozole, an inhibitor of retinoic acid metabolism, exerts retinoid-mimetic effects in vivo.. Journal of Pharmacology and Experimental Therapeutics. 261(2). 773–779. 90 indexed citations
10.
Wauwe, Jean P. Van, M C Coene, J. Goossens, W Cools, & Johan Monbaliu. (1990). Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats.. Journal of Pharmacology and Experimental Therapeutics. 252(1). 365–369. 124 indexed citations
11.
Coster, R. De, et al.. (1989). Comparative Effects of Ketoconazole on Rat, Dog and Human Testicular Steroidogenesis. Journal of enzyme inhibition. 2(4). 261–268. 10 indexed citations
12.
Wauwe, Jean P. Van, et al.. (1988). Ketoconazole inhibits the in vitro and in vivo metabolism of all-trans-retinoic acid.. Journal of Pharmacology and Experimental Therapeutics. 245(2). 718–722. 78 indexed citations
13.
Bossche, H. Vanden, W Cools, J. Gorrens, et al.. (1986). Cytochrome p‐450: Target for itraconazole. Drug Development Research. 8(1-4). 287–298. 74 indexed citations
14.
Willemsens, G., et al.. (1985). 44 Molecular basis for ketoconazole's antifungal and anti-androgen activities. Journal of Steroid Biochemistry. 23. 36–36. 2 indexed citations
15.
Lauwers, W., et al.. (1985). Ketoconazole an inhibitor of the cytochrome P-450 dependent testosterone biosynthesis.. PubMed. 185A. 187–96. 9 indexed citations
16.
17.
Bossche, H. Van den, G. Willemsens, W Cools, Patrick Marichal, & W. Lauwers. (1983). Hypothesis on the molecular basis of the antifungal activity of N-substituted imidazoles and triazoles. Biochemical Society Transactions. 11(6). 665–667. 159 indexed citations
18.
Bossche, H. Van den, G. Willemsens, W Cools, et al.. (1980). In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis. Antimicrobial Agents and Chemotherapy. 17(6). 922–928. 242 indexed citations
19.
Willemsens, G., et al.. (1979). Inhibition of ergosterol synthesis in Candida albicans by ketoconazole [proceedings].. PubMed. 87(4). 849–51. 14 indexed citations
20.
Bossche, H. Van den, G. Willemsens, W Cools, W. Lauwers, & L. Le Jeune. (1978). Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chemico-Biological Interactions. 21(1). 59–78. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026